BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1299660)

  • 1. Folinic acid does not mobilize hemopoietic progenitors following repeated consolidation chemotherapy for acute leukemia.
    Teshima T; Harada M; Takamatsu Y; Inaba S; Kondo S; Akashi K; Okamura T; Niho Y
    J Clin Apher; 1992; 7(4):213-6. PubMed ID: 1299660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia.
    Laporte JP; Douay L; Allieri A; Lopez M; Dupuy Montbrun MC; Mary JY; Giarratana MC; Isnard F; Najman A; Gorin NC
    Br J Haematol; 1990 Apr; 74(4):445-51. PubMed ID: 1971763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of macrophage colony-stimulating factor (M-CSF) on the mobilization of peripheral blood stem cells.
    Eto T; Takamatsu Y; Harada M; Harada N; Akashi K; Teshima T; Inaba S; Okamura T; Niho Y
    Bone Marrow Transplant; 1994 Feb; 13(2):125-9. PubMed ID: 8205080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor.
    Liu KY; Akashi K; Harada M; Takamatsu Y; Niho Y
    Br J Haematol; 1993 May; 84(1):31-8. PubMed ID: 7687859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
    Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
    J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haemopoietic stem cells.
    Teshima T; Harada M; Takamatsu Y; Makino K; Inaba S; Akashi K; Kondo S; Tanaka T; Ishii E; Niho Y
    Br J Haematol; 1993 Aug; 84(4):570-3. PubMed ID: 7692934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting.
    Teshima T; Harada M; Takamatsu Y; Makino K; Taniguchi S; Inaba S; Kondo S; Tanaka T; Akashi K; Minamishima I
    Bone Marrow Transplant; 1992 Sep; 10(3):215-20. PubMed ID: 1384898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folinic acid did not expand the peripheral blood stem cell pool during recovery from consolidation chemotherapy.
    Teshima T; Kondo S; Inaba S; Akashi K; Shibuya T; Harada M; Niho Y
    Br J Haematol; 1991 Aug; 78(4):583. PubMed ID: 1911356
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
    Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
    Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells.
    Pastore D; Specchia G; Mestice A; Liso A; Pannunzio A; Carluccio P; Buquicchio C; Greco G; Ciuffreda L; Pietrantuono G; Liso V
    Bone Marrow Transplant; 2004 Jun; 33(11):1083-7. PubMed ID: 15077126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
    Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
    Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
    Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
    Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
    Thomas X; Raffoux E; Botton Sd; Pautas C; Arnaud P; de Revel T; Reman O; Terré C; Corront B; Gardin C; Le QH; Quesnel B; Cordonnier C; Bourhis JH; Elhamri M; Fenaux P; Preudhomme C; Michallet M; Castaigne S; Dombret H
    Leukemia; 2007 Mar; 21(3):453-61. PubMed ID: 17252021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.